LTF and keratoconus: In conclusion, different PLGA-based NPs were proposed as biocompatible DDS for the lactoferrin administration via topical ophthalmic route, reinforced by several preclinical studies in order to accomplish a reliable base as a new pharmacological alternative for the keratoconus treatment over the invasive surgical procedures.